Home

Embouteillage leau Se rétracter cd90 marker rejet rigidité proposition

Surface Markers of Mesenchymal Stem Cells - Cusabio
Surface Markers of Mesenchymal Stem Cells - Cusabio

CD90 determined two subpopulations of glioma-associated mesenchymal stem  cells with different roles in tumour progression | Cell Death & Disease
CD90 determined two subpopulations of glioma-associated mesenchymal stem cells with different roles in tumour progression | Cell Death & Disease

CD105+CD90+CD13+ identifies a clonogenic subset of adventitial lung  fibroblasts | Scientific Reports
CD105+CD90+CD13+ identifies a clonogenic subset of adventitial lung fibroblasts | Scientific Reports

Hematopoietic Stem Cell Marker (CD34, CD59, CD90 / Thy1, CD38, c-Kit)  Antibody Panel - Human (ab254022)
Hematopoietic Stem Cell Marker (CD34, CD59, CD90 / Thy1, CD38, c-Kit) Antibody Panel - Human (ab254022)

Cluster of differentiation in stem cells | Sino Biological
Cluster of differentiation in stem cells | Sino Biological

Addgene: pMY-CD90.2-Cd247A_miR
Addgene: pMY-CD90.2-Cd247A_miR

CD90 serves as differential modulator of subcutaneous and visceral  adipose-derived stem cells by regulating AKT activation that influences  adipose tissue and metabolic homeostasis | Stem Cell Research & Therapy |  Full Text
CD90 serves as differential modulator of subcutaneous and visceral adipose-derived stem cells by regulating AKT activation that influences adipose tissue and metabolic homeostasis | Stem Cell Research & Therapy | Full Text

Integrin-α3 Is a Functional Marker of Ex Vivo Expanded Human Long-Te
Integrin-α3 Is a Functional Marker of Ex Vivo Expanded Human Long-Te

Anti Dog CD90 Antibody, clone YKIX337.217 | Bio-Rad
Anti Dog CD90 Antibody, clone YKIX337.217 | Bio-Rad

CD90 serves as differential modulator of subcutaneous and visceral  adipose-derived stem cells by regulating AKT activation that influences  adipose tissue and metabolic homeostasis | Stem Cell Research & Therapy |  Full Text
CD90 serves as differential modulator of subcutaneous and visceral adipose-derived stem cells by regulating AKT activation that influences adipose tissue and metabolic homeostasis | Stem Cell Research & Therapy | Full Text

Figures and data in Full spectrum flow cytometry reveals mesenchymal  heterogeneity in first trimester placentae and phenotypic convergence in  culture, providing insight into the origins of placental mesenchymal  stromal cells | eLife
Figures and data in Full spectrum flow cytometry reveals mesenchymal heterogeneity in first trimester placentae and phenotypic convergence in culture, providing insight into the origins of placental mesenchymal stromal cells | eLife

CD90 (Thy-1) Monoclonal Antibody (eBio5E10 (5E10)), FITC (11-0909-42)
CD90 (Thy-1) Monoclonal Antibody (eBio5E10 (5E10)), FITC (11-0909-42)

Blood type and breed-associated differences in cell marker expression on  equine bone marrow-derived mesenchymal stem cells including major  histocompatibility complex class II antigen expression | PLOS ONE
Blood type and breed-associated differences in cell marker expression on equine bone marrow-derived mesenchymal stem cells including major histocompatibility complex class II antigen expression | PLOS ONE

CD90.2 (Thy-1.2) Monoclonal Antibody (53-2.1), FITC (11-0902-82)
CD90.2 (Thy-1.2) Monoclonal Antibody (53-2.1), FITC (11-0902-82)

Thy‐1: more than a marker for mesenchymal stromal cells - Saalbach - 2019 -  The FASEB Journal - Wiley Online Library
Thy‐1: more than a marker for mesenchymal stromal cells - Saalbach - 2019 - The FASEB Journal - Wiley Online Library

CD90/Thy1 Antibody (G7) [FITC] (NBP1-28032): Novus Biologicals
CD90/Thy1 Antibody (G7) [FITC] (NBP1-28032): Novus Biologicals

Purified anti-mouse CD90.1 (Thy1.1) Antibody, CD90.1 (Thy1.1), S20007C
Purified anti-mouse CD90.1 (Thy1.1) Antibody, CD90.1 (Thy1.1), S20007C

Frontiers | CD90/Thy-1, a Cancer-Associated Cell Surface Signaling Molecule
Frontiers | CD90/Thy-1, a Cancer-Associated Cell Surface Signaling Molecule

Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic  Target in Insulinomas | Stem Cells and Development
Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas | Stem Cells and Development

Very Bright Antibody to Detect CD90.1 Congenic Marker on T Cells |  Biocompare Antibody Review
Very Bright Antibody to Detect CD90.1 Congenic Marker on T Cells | Biocompare Antibody Review

Identification of CD90 as a marker for lung cancer stem cells in A549 and  H446 cell lines
Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell lines

Sifting through the haystack: Optimizing hematopoietic stem cell  purification for gene therapy
Sifting through the haystack: Optimizing hematopoietic stem cell purification for gene therapy

Anti Human CD90 Antibody, clone F15-42-1 | Bio-Rad
Anti Human CD90 Antibody, clone F15-42-1 | Bio-Rad

IJMS | Free Full-Text | Expression of Cancer Stem Cell Markers EpCAM and  CD90 Is Correlated with Anti- and Pro-Oncogenic EphA2 Signaling in  Hepatocellular Carcinoma
IJMS | Free Full-Text | Expression of Cancer Stem Cell Markers EpCAM and CD90 Is Correlated with Anti- and Pro-Oncogenic EphA2 Signaling in Hepatocellular Carcinoma

Frontiers | CD90/Thy-1, a Cancer-Associated Cell Surface Signaling Molecule
Frontiers | CD90/Thy-1, a Cancer-Associated Cell Surface Signaling Molecule

Very Bright Antibody to Detect CD90.1 Congenic Marker on T Cells |  Biocompare Antibody Review
Very Bright Antibody to Detect CD90.1 Congenic Marker on T Cells | Biocompare Antibody Review

Expressions of CD44 and CD90 surface marker of synovial membrane (SM)... |  Download Scientific Diagram
Expressions of CD44 and CD90 surface marker of synovial membrane (SM)... | Download Scientific Diagram

Coexpression of CD44 and CD90 as a marker of progression. Top panel:... |  Download Scientific Diagram
Coexpression of CD44 and CD90 as a marker of progression. Top panel:... | Download Scientific Diagram